A new biweekly GLP-1 injection, bofanglutide, reduced blood sugar and produced weight loss in a phase 2b randomized clinical trial, offering a potential alternative to once-weekly…
A large new study links long uninterrupted periods of sitting or lying down to a higher risk of several cancers — but even brief, light movement can make a meaningful difference.
The FDA has cleared EchoNext, the first artificial intelligence tool designed to detect underlying structural heart disease from routine electrocardiograms (ECGs).
A recent large observational study suggests that GLP-1 receptor agonist (GLP-1RA) medications — widely used for type 2 diabetes and increasingly for weight loss — may be linked with a…
Starting July 1, Medicare will launch a new pilot program that lets many Part D beneficiaries buy certain GLP‑1 weight‑loss medications for $50 per month.
In 2000, while finishing her junior year at Michigan State University, Jayme Cohen Lynde felt a small lump on the side of her neck.
Summer heat poses extra risks for people taking GLP-1 medications such as Ozempic, Wegovy, or Mounjaro.
When 10-year-old Taisie Seigrist began drinking huge amounts of water and needing to urinate constantly, her mother Jennifer tested her blood sugar with a borrowed glucose meter and…
A recent analysis suggests that people who start GLP-1 medications such as Ozempic, Wegovy, or Mounjaro tend to do less physical activity after beginning treatment — even though…
Shaquille O’Neal says a GLP-1 medication called Zepbound has helped reduce his obstructive sleep apnea (OSA) symptoms and support weight loss.
AstraZeneca’s experimental oral GLP-1 drug elecoglipron produced substantial reductions in body weight and blood sugar in a phase 2b trial, offering another noninjectable option in the…
New research suggests that regularly adding avocado to your diet can improve markers linked to diabetes, high blood pressure, and cardiometabolic risk.